Your browser doesn't support javascript.
loading
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysis.
Hamimed, Mourad; Leblond, Pierre; Dumont, Aurélie; Gattacceca, Florence; Tresch-Bruneel, Emmanuelle; Probst, Alicia; Chastagner, Pascal; Pagnier, Anne; De Carli, Emilie; Entz-Werlé, Natacha; Grill, Jacques; Aerts, Isabelle; Frappaz, Didier; Bertozzi-Salamon, Anne-Isabelle; Solas, Caroline; André, Nicolas; Ciccolini, Joseph.
Afiliación
  • Hamimed M; SMARTc Unit, Cancer Research Center of Marseille, Inserm U1068-CNRS UMR 7258, Aix-Marseille University U105, 27 Boulevard Jean Moulin, 13385, Marseille, France. mourad.hamimed@univ-amu.fr.
  • Leblond P; Inria-Inserm COMPO Team, Centre Inria Sophia Antipolis - Méditerranée, Inserm U1068-CNRS UMR 7258, Aix-Marseille University U105, Marseille, France. mourad.hamimed@univ-amu.fr.
  • Dumont A; Institute of Pediatric Hematology and Oncology IHOPe, Léon Bérard Cancer Center, Lyon, France.
  • Gattacceca F; Department of Pediatric Oncology, Oscar Lambret Cancer Center, Lille, France.
  • Tresch-Bruneel E; Unité d'Oncologie Moléculaire Humaine, Oscar Lambret Cancer Center, Lille, France.
  • Probst A; SMARTc Unit, Cancer Research Center of Marseille, Inserm U1068-CNRS UMR 7258, Aix-Marseille University U105, 27 Boulevard Jean Moulin, 13385, Marseille, France.
  • Chastagner P; Inria-Inserm COMPO Team, Centre Inria Sophia Antipolis - Méditerranée, Inserm U1068-CNRS UMR 7258, Aix-Marseille University U105, Marseille, France.
  • Pagnier A; Department of Biostatistics, Oscar Lambret Cancer Center, Lille, France.
  • De Carli E; Département de la Recherche Clinique et Innovation, Oscar Lambret Cancer Center, Lille, France.
  • Entz-Werlé N; Service d'Hémato-Oncologie Pédiatrique, Nancy University Hospital, Nancy, France.
  • Grill J; Service d'Hémato-Oncologie Pédiatrique, Grenoble University Hospital, Grenoble, France.
  • Aerts I; Service d'Hémato-Oncologie Pédiatrique, Angers University Hospital, Angers, France.
  • Frappaz D; Pédiatrie Onco-Hématologie Université de Strasbourg, CHRU Hautepierre, UMR CNRS 7021, Strasbourg, France.
  • Bertozzi-Salamon AI; Département de Cancérologie de l'Enfant et de l'Adolescent et UMR CNRS 8203 Université Paris Saclay, Gustave Roussy, Villejuif, France.
  • Solas C; SIREDO Centre (Care, Innovation and Research in Paediatric, Adolescent and Young Adult Oncology), Institut Curie-Oncology Center, Paris, France.
  • André N; Institute of Pediatric Hematology and Oncology IHOPe, Léon Bérard Cancer Center, Lyon, France.
  • Ciccolini J; Service d'Hémato-Oncologie Pédiatrique, Toulouse University Hospital, Toulouse, France.
Cancer Chemother Pharmacol ; 90(1): 29-44, 2022 07.
Article en En | MEDLINE | ID: mdl-35751658
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Farmacogenética / Modelos Biológicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Child / Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Farmacogenética / Modelos Biológicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Child / Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Francia